New CAR-T Therapy Elicits Strong Response in Multiple Myeloma

In a small study, one infusion of the investigational CAR T-cell therapy led to a complete response in most patients with no CAR-T-related neurotoxicity.
Medscape Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *